Alzheimer’s-focused Aprinoia Therapeutics sets terms for M IPO

admin

Alzheimer’s-focused Aprinoia Therapeutics sets terms for $24M IPO


mapo/iStock via Getty Images

Aprinoia Therapeutics (APRI), which terminated a merger deal with Ross Acquisition Corp. II (ROSS) last August, has set terms for a proposed $24M US initial public offering.

The biotech company said in an SEC filing that it is looking to

SOURCE

Leave a Comment